When does Ping An Healthcare report earnings and how does that affect 1833.HK stock?

Ping An Healthcare reports on 03 Mar 2026. Earnings can trigger large moves in 1833.HK stock because current valuation is high, making the stock sensitive to surprises in revenue, margins, or guidance.

What valuation metrics should investors watch for 1833.HK stock?

Focus on trailing PE (**131.70**), PB (**2.36**), and operating margin (**0.75%**). These metrics will determine if the company can justify its premium versus Hong Kong healthcare peers.

What is Meyka AI's short-term forecast for 1833.HK stock?

Meyka AI's model projects **monthly HK$12.26** and **quarterly HK$17.90**. Short-term moves will depend on earnings detail and guidance; model projections are not guarantees.

Are there technical signals to watch for 1833.HK stock after the decline?

Yes. Key signals include RSI at **30.56** and the stock trading below its 50-day (**HK$14.91**) and 200-day (**HK$13.94**) averages. These suggest short-term oversold conditions but persistent resistance.

HK Stocks

Down 7.06%: 1833.HK Ping An Healthcare (HKSE) 02 Mar 2026: earnings valuation test

ByDanny Kontos March 2, 2026March 2, 2026

The market closed with 1833.HK stock at HK$12.12, down 7.06% on heavy volume of 23,229,741.00 shares as investors priced-in an upcoming earnings release. Ping An Healthcare and Technology Company Limited (1833.HK) reports results on 03 Mar 2026, a catalyst after today’s sell-off. Traders cite stretched valuation and mixed margin signals as immediate drivers. We examine the financials, technicals, Meyka AI grading, and forecast to frame the earnings risk and opportunity for Hong Kong investors.